What's on

The Programme

Filter by Category:

Morning Sessions

INFORMATION

DAY 3

Chaired by: Dr Pranab Haldar (Leicester)

INFORMATION

DAY 3

Chaired by: Professor Liam Heaney (Belfast) and Dr Maisha Jabeen (Oxford)

9:00am

Overcrowding in the asthmatic airway: the consequences of bronchospasm
Professor Jody Rosenblatt (London)

9:30am

Greater than the sum of their parts: mast cell – eosinophil interactions in asthma
Professor Sven-Erik Dahlén (Sweden)

10:00am Upside down: epithelial responses to eosinophil targeting
Dr Hitasha Rupani (Southampton)

 

INFORMATION

DAY 3

Chaired by: Dr Katie Ward (London) and Dr Rahul Mahida (Birmingham)

9:00am

Mechanisms of autoimmunity in ILD 
Professor Joanna Porter (London

9:30am

Navigating the spectrum of vasculitis in ILD 
Professor David Jayne (Cambridge)

10:00am Phenotyping the myositis patient and tailoring management to specific subtypes
Dr Harsha Gunawardena (Bristol)

 

INFORMATION

DAY 3

Chaired by: Professor Robert Gray (Glasgow) and Dr Dawn Lau (Cardiff)

9:00am

Covering changing microbial ecology and potential new approached such as phage therapy
Professor Jo Fothergil (Liverpool)

9:30am

What can we learn from large animal models of CF and non-CF Bronchiectasis?
Professor David Stoltz (USA)

10:00am Exploring how understanding non-pathogen driven autoinflammation may be the key to treating residual inflammation in the CF lung following CFTR modulator therapy
Professor Daniel Peckham (Leeds)

 

INFORMATION

DAY 3

Chaired by: Professor Gary Lee (Perth) and Dr Selina Tsim (Glasgow)

10:45am

Genetic mechanisms in pneumothorax and cystic lung diseases
Professor Stefan Marciniak (Cambridge)

11:15am

Macrophage subtypes and cellular immunity in pleural infection
Professor Laura Gleeson (Dublin)

11:45am Pleural septation detection, formation and biology – insights from early phase studies 
Dr Eihab Bedawi (Oxford)

 

INFORMATION

DAY 3

Chaired by: Dr Vicky Moore (Coventry) and Professor Luke Howard (London)

10:45am

Specialist nursing: physiological data within severe asthma, the path to therapeutics 
Katie Borg (Oxford)

11:15am

Physiotherapy: physiological data for dysfunctional breathing, a growing evidence base
Chelliah Paramasivan (Cambridge)

11:45am

Physician clinics: physiology data in pulmonary vascular disease, what’s new?
Dr Martin Johnson (Scotland) 

 

INFORMATION

DAY 3

Chaired by: Dr Andy Molyneux (Mansfield)

10:45am

New assessment pathways for patients attending hospital with exacerbations of COPD or asthma
Dr James Dodd (Bristol) 

11:15am

Findings from analysis of oxygen safety incidents related to type 2 acute respiratory failure
Dr Hamish Duff (Bristol)

11:45am

National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report on pleural procedures
Dr Mark Juniper (Swindon)

 

Early Afternoon Sessions

INFORMATION

Why this bill matters: tobacco, vaping and the future of lung health

DAY 3

Professor Sanjay Agrawal (Leicester)
Introduced by Professor Elizabeth Sapey (Birmingham)

INFORMATION

DAY 3

Chaired by: Dr Sonya Craig (Liverpool) and Helen May (Manchester)

1:45 pm

Gender differences in obstructive sleep apnoea 
Dr Renata Riha (Scotland)

2:15 pm

MAD plus CPAP: does combining two established treatments for obstructive sleep apnoea give added benefits? 
Dr Tim Quinnell (Cambridge

2:45 pm

Complex sleep apnoea and ASV: evidence, controversies, and patient selection
Professor Esther Schwarz (Zurich)

 

INFORMATION

DAY 3

Chaired by: Dr Frances Grudzinska (Nottingham) and Dr Meg Coleman (London)

1:45 pm

Host immune responses and corticosteroid effects in severe CAP
Professor Thomas Wilkinson (Southampton)

2:15 pm

Effect of steroids on mortality in patients with severe community-acquired pneumonia: The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial in context
Professor Anthony Gordon (London)

2:45 pm

NICE guidelines in context – steroids in pneumonia 
Dr Tom Bewick (Derby)

 

INFORMATION

DAY 3

Chaired by: Professor David Lomas (London) and Dr Samantha Walker (ALUK)

1:45 pm

New and known pathological pathways as novel targets during the early phases of chronic respiratory disease
Dr Renata Jurkowska (Cardiff)

2:15 pm

Preventing acute microbial-driven exacerbations from destabilising lung function and worsening chronic disease
Dr Aurelie Crabbe (Belgium)

2:45 pm

Opportunities for targeting common cross-disease mechanisms to prevent progression of chronic lung diseases
Dr Amanda Tatler (Nottingham)

 

Late Afternoon Sessions

INFORMATION

DAY 3

Chaired by: Dr Liz Fuller (Newcastle) and Dr Alexandra Teagle (Plymouth)

3:30 pm

Expanding roles of liquid biopsies for lung cancer: detection, residual disease, surveillance and beyond
Professor Nitzan Rosenfeld (London)

4:00 pm

Second primary lung cancers – who is at risk and how long should we follow people up?  
Professor Robert Rintoul (Cambridge)

4:30 pm

LungVax: early interception and prevention in the lung cancer setting 
Professor Mariam Jamal-Hanjani (London)

 

INFORMATION

DAY 3

Chaired by: Professor Alice Turner (Birmingham) and Dr Hannah Burke (Southampton)

3:30 pm

Patient centred innovation – overcoming health inequalities 
Professor Ian Sinha (Liverpool)

5:45 pm

Respiratory innovation and improvement in primary care 
Dr Katherine Hickman (Leeds) 

4:15 pm

Driving impact from new therapies
Professor James Dodd (Bristol) and Dr Irem Patel (London)